Compare ARK Genomic Revolution ETF (ARKG) vs ING Groep NV (ING) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs ING Groep NV — how do they compare? ARK Genomic Revolution ETF trades at $44.36, while ING Groep NV trades at $35.49 (market cap $101.22B). The key difference: ING Groep NV pays a 3.73% dividend while ARK Genomic Revolution ETF pays none. Which is the better fit depends on your goals.
| ARKG | ING | |
|---|---|---|
Sector | Sector/Thematic | Financials |
52-Week High | $44.55 | $35.92 |
52-Week Low | $24.02 | $23.66 |
Market Cap | — | $101.22B |
Dividend Yield | — | 3.73% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About ING Groep NV
The merger of the Dutch postal bank and NN Insurance in 1991 created ING. Through a series of further acquisitions ING build up a global footprint. The 2008 financial crisis forced ING to seek government support--a precondition of which was that ING should separate its banking and insurance activities, which saw ING revert to being solely a bank. ING has market- leading banking operations in the Netherlands and Belgium, and a range of digital banks across Europe and Australia. Its global wholesale banking operation is primarily focused on lending.
Read more on ING →
